Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Deficit

v3.23.1
Consolidated Statements of Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Deferred Stock Based Compensation [Member]
Stock Subscription [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 49 $ 11,023,738 $ (148,333) $ (25,000) $ (15,911,895) $ (5,061,441)
Beginning Balance, shares at Dec. 31, 2020 7,650 281 486,806          
Adjustment to common stock to reconcile to transfer agent  
Adjustment to common stock to reconcile to transfer agent, shares   (2,127)          
Compensation expense due to warrant modification 109,206 109,206
Conversion of bridge notes and accrued interest to common stock $ 17 4,378,471 4,378,488
Conversion of bridge notes and accrued interest to common stock, shares   165,692          
Conversion of debentures and accrued expenses $ 2 515,067 515,069
Conversion of debt and accrued interest, shares   15,825          
Conversion of Series A preferred stock to common stock $ 2 662,498 (542,500) 120,000
Conversion of Series A preferred stock to common stock, shares     18,750          
Exercise of Series B Warrants to common stock     $ 5 467,852   467,857
Exercise of Series B Warrants to commomn stock, shares     46,786          
Series B, preferred stock contractual dividends (153,343) (153,343)
Incremental value from warrant modifications 850,214 (850,214)
Fair value allocation of warrants issued with convertible notes 72,600 72,600
Issuance of Series B, conversion of notes payable with directors to preferred stock 23,000 23,000
Issuance of Series B, conversion of notes payable to preferred stock, shares   23            
Issuance of Series B, preferred stock for cash $ 2 2,195,998 25,000 2,221,000
Issuance of Series B, preferred stock for cash, shares   2,196            
Conversion of Series B preferred stock to common stock $ 16 (16)
Conversion of Series B preferred stock to common stock, shares   (991) 163,134          
Series A, preferred stock contractual dividends (29,538) (29,538)
Common stock issued for services, including a director $ 4 922,388 148,333 1,070,725
Stock-based compensation for services, shares     36,250          
Stock-based compensation to employees and directors 6,603,691 (1,307,593) 5,296,098
Stock-based compensation to employees and directors, shares 850              
Conversion of Series E Preferred Stock to common stock     $ 72 2,123,756 406,851     2,530,679
Conversion of Series E preferred stock to common stock, shares (8,500)   720,986          
Net loss (11,977,065) (11,977,065)
Issuance of common stock for cash, shares              
Ending balance, value at Dec. 31, 2021 $ 2 $ 165 29,765,585 (900,742) (29,281,674) (416,664)
Ending balance, shares at Dec. 31, 2021 1,509 1,652,102          
Conversion of bridge notes and accrued interest to common stock, shares     5,469          
Conversion of debentures and accrued expenses $ 3 113,648 113,651
Conversion of debt and accrued interest, shares   27,624          
Series B, preferred stock contractual dividends (151,309) (151,309)
Incremental value from warrant modifications 41,225 (41,225)
Series A, preferred stock contractual dividends (27,620) (27,620)
Common stock issued for services, including a director $ 12 632,739 (150,589) 482,162
Stock-based compensation for services, shares     118,750          
Net loss (5,481,291) (5,481,291)
Deemed dividend from Series A conversion price adjustment 342,497 (342,497)
Deemed dividend from Series B conversion price adjustment 30,938 (30,938)
Accretion of stock-based compensation to employees and directors 670,962 864,002 1,534,964
40:1 Reverse Split Fractional Shares Adjustment
Issuance of common stock for cash, shares   266          
Issuance of common stock for cash $ 31 1,402,469 1,402,500
Issuance of common stock for cash, shares   311,666          
Conversion of deferred employee compensation $ 17 606,981 606,998
Conversion of deferred employee compensation, shares     168,611          
Ending balance, value at Dec. 31, 2022 $ 2 $ 228 $ 33,428,115 $ (187,329) $ (35,177,625) $ (1,936,609)
Ending balance, shares at Dec. 31, 2022 1,509 2,279,019